Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months

• Váldodahkkit: Rima R. Sahay (Dahkki), Pragya D. Yadav (Dahkki), Ashok Nandapurkar (Dahkki), Rutuja Dhawde (Dahkki), Annasaheb Suryawanshi (Dahkki), Deepak Y. Patil (Dahkki), Anita M. Shete (Dahkki), Gajanan N. Sapkal (Dahkki), Milind Kulkarni (Dahkki), Yogesh K. Gurav (Dahkki), Gururaj R. Deshpande (Dahkki), Jagdevi S. Ghodke (Dahkki), Rajlaxmi Jain (Dahkki), Raj Hawale (Dahkki), Kaumudi Kalele (Dahkki), Jyoti Yemul (Dahkki), Pranita Gawande (Dahkki), Priya Abraham (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

We have evaluated the immunogenicity of two dose of Covaxin given at a one-month interval to two adult populations, i.e. COVID-19 naïve-vaccinated individuals (n = 118) and COVID-19 recovered individuals (n = 128) with the vaccination. The immune response in the study population were assessed at thr...